Inflammatory disorder affecting predominantly the central face, rarely affecting pts <30 years of age. Tendency toward exaggerated flushing, with eventual superimposition of papules, pustules, and telangiectases. May lead to rhinophyma and ocular problems.

TREATMENT
Oral tetracycline, 250-1000 mg/d; topical metronidazole and topical nonfluorinated glucocorticoids may be useful.